Guardian Pharmacy Services, Stock Performance
| GRDN Stock | 24.94 0.02 0.08% |
Guardian Pharmacy holds a performance score of 21 on a scale of zero to a hundred. The company retains a Market Volatility (i.e., Beta) of 1.02, which attests to a somewhat significant risk relative to the market. Guardian Pharmacy returns are very sensitive to returns on the market. As the market goes up or down, Guardian Pharmacy is expected to follow. Use Guardian Pharmacy Services, coefficient of variation, semi variance, price action indicator, as well as the relationship between the treynor ratio and daily balance of power , to analyze future returns on Guardian Pharmacy Services,.
Risk-Adjusted Performance
21 of 100
Weak | Strong |
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Guardian Pharmacy Services, are ranked lower than 21 (%) of all global equities and portfolios over the last 90 days. In spite of very weak fundamental indicators, Guardian Pharmacy displayed solid returns over the last few months and may actually be approaching a breakup point. ...more
Actual Historical Performance (%)
One Day Return (0.08) | Five Day Return 6.9 | Year To Date Return 55.88 | Ten Year Return 55.88 | All Time Return 55.88 |
1 | Guardian Pharmacy director buys 99,988 in company stock | 10/01/2024 |
2 | Truist Financial Begins Coverage on Guardian Pharmacy Services | 10/21/2024 |
3 | Wellington Management Group LLP Acquires New Stake in Guardian Pharmacy Services Inc | 11/08/2024 |
4 | Alyeska Investment Group, L.P. Acquires New Stake in Guardian Pharmacy Services Inc | 11/15/2024 |
5 | Foundry Partners LLC Invests 1.68 Million in Guardian Pharmacy Services, Inc. - MarketBeat | 11/22/2024 |
| Begin Period Cash Flow | 607 K | |
| Free Cash Flow | 56.3 M |
Guardian |
Guardian Pharmacy Relative Risk vs. Return Landscape
If you would invest 1,600 in Guardian Pharmacy Services, on September 2, 2024 and sell it today you would earn a total of 894.00 from holding Guardian Pharmacy Services, or generate 55.88% return on investment over 90 days. Guardian Pharmacy Services, is currently generating 1.0159% in daily expected returns and assumes 3.6934% risk (volatility on return distribution) over the 90 days horizon. In different words, 32% of stocks are less volatile than Guardian, and 80% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Guardian Pharmacy Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Guardian Pharmacy's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Guardian Pharmacy Services,, and traders can use it to determine the average amount a Guardian Pharmacy's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.2751
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | GRDN | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 3.69 actual daily | 32 68% of assets are more volatile |
Expected Return
| 1.02 actual daily | 20 80% of assets have higher returns |
Risk-Adjusted Return
| 0.28 actual daily | 21 79% of assets perform better |
Based on monthly moving average Guardian Pharmacy is performing at about 21% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Guardian Pharmacy by adding it to a well-diversified portfolio.
Guardian Pharmacy Fundamentals Growth
Guardian Stock prices reflect investors' perceptions of the future prospects and financial health of Guardian Pharmacy, and Guardian Pharmacy fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Guardian Stock performance.
| Revenue | 1.05 B | ||||
| Net Income | 23.9 M | ||||
| Total Debt | 12.98 M | ||||
| Cash Flow From Operations | 70.82 M | ||||
| Total Asset | 271.17 M | ||||
About Guardian Pharmacy Performance
By examining Guardian Pharmacy's fundamental ratios, stakeholders can obtain critical insights into Guardian Pharmacy's financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that Guardian Pharmacy is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
Guardian Pharmacy is entity of United States. It is traded as Stock on NYSE exchange.Things to note about Guardian Pharmacy performance evaluation
Checking the ongoing alerts about Guardian Pharmacy for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Guardian Pharmacy help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Guardian Pharmacy appears to be risky and price may revert if volatility continues | |
| Guardian Pharmacy has a frail financial position based on the latest SEC disclosures | |
| Latest headline from news.google.com: Foundry Partners LLC Invests 1.68 Million in Guardian Pharmacy Services, Inc. - MarketBeat |
- Analyzing Guardian Pharmacy's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Guardian Pharmacy's stock is overvalued or undervalued compared to its peers.
- Examining Guardian Pharmacy's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Guardian Pharmacy's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Guardian Pharmacy's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Guardian Pharmacy's stock. These opinions can provide insight into Guardian Pharmacy's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Guardian Pharmacy Services,. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Is Retail space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Guardian Pharmacy. If investors know Guardian will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Guardian Pharmacy listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Guardian Pharmacy is measured differently than its book value, which is the value of Guardian that is recorded on the company's balance sheet. Investors also form their own opinion of Guardian Pharmacy's value that differs from its market value or its book value, called intrinsic value, which is Guardian Pharmacy's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Guardian Pharmacy's market value can be influenced by many factors that don't directly affect Guardian Pharmacy's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Guardian Pharmacy's value and its price as these two are different measures arrived at by different means. Investors typically determine if Guardian Pharmacy is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Guardian Pharmacy's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.